Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

by Ysios Capital

Aura Biosciences today announced positive data from a completed Phase 1 window of opportunity trial of bel-sar (AU-011) in patients with NMIBC. These data were presented by Dr. Seth Lerner as a late b...

Read more

A study identifies a key protein in the response to 'one-two' therapies in oncology

by IdiBGi

Researchers from the ProCURE ICO-Girona/IDIBGI program find one of the keys to improving the elimination of senescent tumor cells.

Read more

Vall d’Hebron shows long-term safety of CAR-T therapy in aggressive lymphoma patients

by VHIO

The results show the need for continuous monitoring of patients to detect and manage possible adverse effects occurring months and years after treatment.

Read more

Nuevos materiales avanzados contra el cáncer

by Universitat Politècnica de València

El proyecto se centra en el desarrollo de materiales conocidos como metal-organic frameworks (MOFs), diseñados para encapsular y liberar fármacos de forma controlada.

Read more

IDIBAPS launches an AECC-funded excellence programme to improve the response to immunotherapy in cancer

by Fundació Clínic per a la Recerca Biomèdica

On Thursday 13 March 2025, IDIBAPS held the first meeting of the new research project ‘AECC-IDIBAPS Excellence Programme: Immunotherapy Against Cancer’. Funded by the Spanish Association Against C...

Read more

Aromics joins the BME Pre-Market Environment

by AROMICS

The company develops innovative compounds that that RNA of cancer-driven genes. Its lead compound, currently advancing into the clinical phase, targets the treatment of malignant mesothelioma, a disea...

Read more

Un nuevo diseño de nanopartículas optimiza las terapias contra el cáncer y mejora el seguimiento por imagen

by Bionand

Innovadoras nanopartículas mejoran la eficiencia de la hipertermia magnética y permiten su seguimiento en tiempo real, optimizando el tratamiento y monitorización de tumores.

Read more

Una investigación del CNIO descubre cómo el melanoma y otros tumores logran ocultarse y resistir a la inmunoterapia

by CNIO - Centro Nacional de Investigaciones Oncológicas

Las células de melanoma, el cáncer de piel más agresivo, producen una proteína que bloquea el reconocimiento y eliminación del tumor por parte del sistema inmunitario, las defensas naturales del ...

Read more

Study Reveals How Key Mutation in Blood Cancers Reprograms Cell Metabolism by Altering Mitochondrial Function

by Hospital de la Santa Creu i Sant Pau

The study shows that the KIT D816V mutation—frequently found in hematologic malignancies such as acute myeloid leukemia (AML) and systemic mastocytosis—increases both the number and activity of mi...

Read more

Colonoscopy and faecal occult blood tests are equivalent in detecting colorectal cancer

by Fundació Clínic per a la Recerca Biomèdica

Researchers at IDIBAPS-Hospital Clínic and Hospital Universitario de Canarias have coordinated a study involving 57,000 people that compares the effectiveness of the two main strategies for screening...

Read more

A UEx study analyzes the quality of life of people with Lynch Syndrome in Extremadura

by Universidad de Extremadura

Lynch syndrome is one of the most prevalent hereditary cancer syndromes in humans, predisposing to the development of various types of cancer, primarily colorectal and endometrial cancer, but also ski...

Read more

The potential of exosomes in regenerative medicine

by Sermes CRO

Regenerative medicine has advanced significantly in recent decades, and one of the most promising discoveries in this field is exosomes. These tiny extracellular vesicles are revolutionizing how we un...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream